Human herpesvirus type 6 and type 7 in transplant recipients;Virus del herpes humano tipo 6 y tipo 7 en receptores de trasplantes

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 8, 2003, Pages 424-432

  Benito, Natividad ^a   Moreno, Asunción ^a   Pumarola, Tomás ^a   Marcos, Ma Angeles ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Beta herpesviruses; Bone marrow transplantation; Hematopoietic stem cell transplantation; Human herpesvirus 6 (HHV 6); Human herpesvirus 7 (HHV 7); Solid organ transplantation; Transplantation

Indexed keywords

ACICLOVIR; GANCICLOVIR;

BONE MARROW SUPPRESSION; CYTOMEGALOVIRUS; GRAFT FAILURE; GRAFT REJECTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIMARY INFECTION; REVIEW; TRANSPLANTATION; VIRUS LATENCY; VIRUS REACTIVATION;

EID: 0142059065     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051907     Document Type: Review

References (104)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, et al. Isolation of a new virus, HBLV, in patients with lymphoprolifertative disorders. Science 1986;234:596-601.
2. Caserta MT, Mock DJ, Dewhurst S. Human herpesvirus 6. Clin Infect Dis 2001;33:829-33.
3. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis 1999;5:353-66.
4. Braun DK, Domínguez G, Pellet PE. Human herpesvirus 6. Clin Microbiol Rev 1997;10:521-67.
5. Frenkel N, Schirmer EC, Wyatt LS, Wyatt LS, Katsafanas G, Roffman E, et al. Isolation of a new herpesvirus from human CD4+ cells. Proc Natl Acad Sci USA 1990;87:748-52.
6. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin ME, et al. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution. Virology 1995;209:29-51.
7. Domínguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE, et al. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 1999; 73: 8040-52.
8. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol 1996;70:5975-89.
9. Santoro F, Kenny PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999;99:817-27.
10. Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, Gallo RC, et al. CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus. Proc Natl Acad Sci USA 1994;91:3872-6.
11. Dockrell DH, Payá CV. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 2001;11:23-36.
12. Yasukawa M, Yakushijin Y, Furukawa M, Fujita S. Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol 1993;67:6259-64.
13. Flamand L, Gossehn J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpes virus 6 on T cell function: Suppression of interleukin-2 synthesis and cell proliferation. Blood 1995;85: 1263-71.
14. Flamand L, Gossehn J, Stefanescu I, Ablashi D, Menezes J. Human herpesvirus 7 induces CD4+ T-cell apoptosis by human herpesvirus 6. J Virol 1997; 71:3751-9.
15. Inoue Y, Yasukawa M, Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J Virol 1997;71:3751-9.
16. Secchiero P, Flamand L, Gibellini D, Falcieri E, Robuffo I, Capitani S, et al. Human herpesvirus 7 induces CD4+ T-cell death by two distinct mechanisms: Necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood 1997;90:4502-12.
17. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC. Infection of natural killer cells by human herpesvirus 6. Nature 1993;362: 458-62.
18. Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996;97:1373-81.
19. Atedzoe BN, Ahmad A, Menezes J. Enhancement of natural killer cell citotoxicity by the human herpesvirus-7 via IL-15 induction. J Immunol 1997; 159:4966-72.
20. Burd EM, Carrigan DR. Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res 1993;29:79-90.
21. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interlukin-6, in peripheral blood mononuclear cell cultures. J Virol 1991;65:5105-10.
22. Hall CB, Long CE, Shnabel KC, Caserta MT, McIntyre KM, Costanzo MA, et al. Human herpesvirus-6 infection in children: A prospective study of complications and reactivation. N Engl J Med 1994;331:432-8.
23. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;1:1065-7.
24. Pruksannanonda P, Hall CB, Insel RA, McIntyre KM, Pellet PE, Long CE, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992;331:432-8.
25. Portolani M, Cermelli C, Moroni A, Bertolani MF, Di Luca D, Cassai E, et al. Human herpesvirus-6 infections in infants admitted to hospital. J Med Virol 1993;39:146-51.
26. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, et al. Brief report: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329: 168-71.
27. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K. Human herpesvirus 7: Another causal agent for roseola (exantema subitum). J Pediatr 1994;125:1-5.
28. Ueda K, Kusuhara K, Okada K, Miyazaki C, Hidaka Y, Tokugawa K, et al. Primary human herpesvirus 7 infection and exanthema subitum. Pediatr Infect Dis J 1994;13:167-8.
29. Torigoe S, Koide W, Yamada M, Miyashiro E, Tanaka-Taya K, Yamanishi K. Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr 1996;129:301-5.
30. Civeira MP, Cuende I, Castilla A, Prieto J. Prevalencia de anticuerpos frente al virus herpes humano 6 (VHH-6 o HBLV) en la población general. Med Clin (Barc) 1989;92:199.
31. Okuno T, Takabashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol. 1989;27:651-3.
32. Di Luca D, Mirandola P, Ravaioli T, Bigoni B, Cassai E. Distribution of HHV-6 variants in human tissues. Infectious agents and disease 1996;5: 203-14.
33. Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990;335:1047-50.
34. Harnett GB, Farr TJ, Pietroboni GR, Bucens MR. Frequent sedding of human herpesvirus 6 in saliva. J Med Virol 1990;30:128-30.
35. Di Luca D, Mirandola P, Ravaioli T, Dolcetti R, Frigatti A, Bovenzi P, et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995;45:462-8.
36. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, et al. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 2001;63:45-51.
37. Chan PK, Ng HK, Hui M, Ip M, Cheung JL, Cheng AF. Presence of human herpesviruses 6, 7, and 8 DNA sequences in normal brain tissue. J Med Virol 1999;59:491-5.
38. Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994;170:1586-9.
39. Singh N, Paterson DL. Encephalitis caused by human herpesvirus-6 in transplant recipients: Relevance of a novel neurotropic virus. Transplantation 2000;69:2474-9.
40. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995;21:571-6.
41. Kempf W, Volker A, Mirandola P, Menotti L, Di Luca D, Wey N, et al. Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J Infect Dis 1998;178:841-5.
42. Knox KK, Carrigan DR. Disseminated active HHV-6 infections in patients with AIDS. Lancet 1994;343:577-8.
43. Lusso P, Gallo RC. HHV-6 and CMV pneumonitis in immunocompromised patients. Lancet 1994;343:1647-8.
44. Clark DA, Ait Khaled M, Wheeler AC, Kidd IM, McLaughlin JE, Johnson MA, et al. Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J Gen Virol 1996;77:2271-5.
45. Moschettini D, De Milito A, Catucci M, Marconi A, Rinina C, Bianchi-Bandinelli ML, et al. Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method. Eur J Clin Microbiol Infect Dis 1998;17:117-9.
46. Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999;59:496-501.
47. Singh N, Carrigan Donald R. Human Herpesvirus-6 in Transplantation: An emerging pathogen. Ann Intern Med 1996;124:1065-71.
48. Boutolleau D, Fernández C, André E, Imbert-Marcille BM, Milpied N, Agut H, et al. Human herpesvirus (HHV)-6 and HHV-7: Two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 2003;187:179-86.
49. Griffiths PD, Clark DA, Emery VC. Betaherpesviruses in transplant recipients. J Antimicrob Chemother 2001;45:29-34.
50. Ljungman P. β-herpesvirus challenges in the transplant recipient. J Infect Dis 2002;186(Suppl);99-109.
51. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Fever in liver transplant recipients: Changing spectrum of etiologic agents. Clin Infect Dis 1998;26:59-65.
52. Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S, et al. Human herpesvirus 6 viremia in bone marrow trasnsplant recipients: Clinical features and risk factors. J Infect Dis 2002;185:847-53.
53. Humar A, Kumar D, Caliendo AM, Moussa G, Ashi-Sulaiman A, Levy G, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002;73:599-604.
54. Razonable RR, Rivero A, Brown RA, Espy MJ, Wilson JA, Groettum C, et al. Human herpes virus (HHV) 6 and HHV7 cause cytomegalovirus (CMV)-negative syndromes among transplant patients (TXP) (abstract 444). Clin Infect Dis 2001;33:1164.
55. Razonable RR, Payá CV. The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation. Liver Transpl 2002;8:651-8.
56. Lautenschlager I, Härmä M, Höckerstodt K, Linnavuori K, Loginov R, Taskinen E. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol 2002;37:648-54.
57. Lautenschlager I, Höckerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998;26: 702-7.
58. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringdén O, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haemat 2000;111:774-81.
59. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
60. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differenciation by human herpesvirus 6 infection. J Infect Dis 1992;165: 925-9.
61. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995;23:626-9.
62. Carrigan DR, Knox KK. Bone marrow suppression by human herpesvirus-6: Comparison of the A and B variant of the virus. Blood 1995;86:835-6.
63. Rossi C, Delforge ML, Jacobs F, Wissing M, Pradier O, Remmlink M, et al. Faltal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation 2000;71:288-92.
64. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febril dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995;60: 1355-57.
65. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity. Transplantation 1997;64:674-8.
66. Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient. Clin Infect Dis 1996;22:174-5.
67. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991;338:147-9.
68. Coned RW, Hackman RC, Huang MW, Bowden RA, Meyers JD, Metcalf M, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993;329:156-61.
69. Cone RW, Huang ML, Hackman RC, Corey L. Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 1996;34: 877-81.
70. Singh N, Paterson D. Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000;69:2474-9.
71. Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it have clinical significance? Clin Infect Dis 1999;28:562-8.
72. Paterson DL, Singh N, Gayowski T, Carrigan DR, Marino IR. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. Liver Transpl Surg 1999;5:454.
73. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995;60: 1355-7.
74. Chan PKS, Peiris JSM, Yuen KY, Liang RHS, Lau YL, Chen FE, et al. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. J Med Virol 1997;53:295-305.
75. Humar A, Malkan G, Moussa G, Greig P, Levy G, Mazzulli T. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000;181:1450-3.
76. DesJardin J, Cho E, Supran S, Gibbons L, Werner BG, Snydman DR. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis 2001;33:1358-62.
77. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, et al. et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997;176:1135-40.
78. Mendez JC, Dockrell DH, Espy MJ, Smith TF, Wilson JA, Harmsen WS, et al. Human β-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 2001;183:179-84.
79. Lautenschlager I, Lappalainen M, Kinnavuori K, Suni J, Höckerstedt K. CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. J Clin Virol 2002;25(Suppl 2): 57-6.
80. Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarret RF, Madeley CR. "Cytomegalovirus disease" in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression? J Med Virol 1996;48:295-301.
81. DesJardins JA, Gibbons L, Eunhui C, Supran SE, Falagas ME, Werner BG, et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998;178:1783-6.
82. Ratnamohan VM, Chapman J, Howse H, Bovington K, Robertson P, Karen B, et al. Cytomegalovirus and human herpesvirus both cause viral disease after renal transplantation. Transplantation 1998;66:877-82.
83. Kidd IM, Clark DA, Sabin C, Andrew D, Hassan-Walker AF, Sweny P, et al. Prospective study of human betaherpesviruses after renal transplantation: Association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 2000;69:2400-4.
84. Tong CYW, Bakran A, Williams H, Cheung CY, Peiris JSM. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation 2000;70:213-6.
85. Kadakia MP, Ribka WB, Stewart JA, Kadakia MP, Rybka WB, Stewart JA, et al. Human herpesvirus-6: Infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996;87:5341-54.
86. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993;67: 6768-77.
87. Schonnebeck M, Krueger GR, Braun M, Fischer M, Koch B, Ablashi DV, et al. Human hevpesvirus-6 infection may predispose cells to superinfection by other viruses. In vivo 1991;5:255-63.
88. Singh N, Husain S, Carrigan DR, Know KK, Weck KE, Wagener MM, et al. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002;16:92-6.
89. Lautenschlager I, Linnavuori K, Höckerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 2000;69:2561-6.
90. Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996;88:3615-20.
91. Maeda Y, Teshima T, Yamada M, Shinagawa K, Nakao S, Ohno Y, et al. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Brit J Haemat 1999;105:295-302.
92. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: Serologic features and detection by polymerase chain reaction. Blood 1994;83:3052-8.
93. Appleton AL, Sviland L, Peiris JSM, Taylor CE, Wilkes J, Green MA, et al. Human herpesvirus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease. Bone Marrow Transplant 1995;16: 777-82.
94. Dockrell DH, Méndez JC, Jones M, Harmsen WS, Ilstrup DM, Smith TF, et al. Human herpesvirus-6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999;67:399-403.
95. Rogers J, Rohal S, Carrigan D, Kusne S, Knox K, Gayowski T, et al. Human herpesvirus-6 in liver transplant recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000; 69:2566-73.
96. Saxinger C, Polesky H, Eby N, Grufferman S, Murphy R, Tegtmeir G, et al. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods 1988;21:199-208.
97. Dockrell DH, Smith TF, Payá CV. Human herpesvirus 6. Mayo Clin Proc 1999;74:163-70.
98. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, et al. Detection of human herpesvirus 6 in plasm of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-80.
99. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 1995;33:2124-30.
100. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet AM, Mangeney N, Vidaud M, et al. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 2002;100:27-35.
101. Kidd IM, Clark DA, Bremner JAG, Pillay D, Griffiths PA, Emery VC. A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Methods 1998;70:29-36.
102. Emery VC. Human herpesviruses 6 and 7 in solid organ transplant recipients. Clin Infect Dis 2001;32:1357-60.
103. Clark DA. Human herpesvirus 6. Rev Med Virol 2000;10:155-73.
104. Black JB, Pellet PE. Human herpesvirus 7. Rev Med Virol 1999;9:245-62.